Search results
Results From The WOW.Com Content Network
A Drug Enforcement Administration (DEA) judge canceled an upcoming hearing on the Biden administration’s marijuana rescheduling proposal pending appeals, effectively kicking the process to the ...
An administrative law judge nixed a DEA hearing on the proposed rescheduling of marijuana set to take place next week, pushing the hearing well into President-elect Donald Trump's next administration.
DEA lawsuit NO. 20-71433, the Ninth Circuit dismissed a petition that asked the court to review the DEA's denial of a letter that requested the agency reschedule marijuana. Under the CSA, the DEA must begin investigating the rescheduling of a drug after receiving a petition by from any interested party, including the manufacturer of a drug, a ...
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
Health and Human Services recommended that DEA reschedule marijuana to Schedule III in 2023. For decades, cannabis has been classified as a Schedule I drug, a class defined as drugs with no ...
The DEA's decision will be followed by a 60-day public review period. It was not immediately clear when the proposed rule would be open to public comment. ... But rescheduling marijuana doesn’t ...
"What happened yesterday (the DEA recommending rescheduling marijuana) is really a kick in the pants," said Sen. Ron Wyden, D-Ore. "Descheduling is a Republican's dream. This is a monument to ...
What rescheduling means. Since 1971, marijuana has been in the same category as heroin, methamphetamines and LSD. Each substance under the Schedule I classification is defined as a drug with no ...